< img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4285980&fmt=gif" />
en
Search
Home
Customer Testimonials
Small Molecule
Mol2Med™ Integrated Services
Developability Assessment
API Form and Solid-State Research
Crystallization Development
Pre-formulation Studies
Formulation and Analytical Development
GMP Manufacturing
Clinical Supply
Crystal Bio
Competitive Advantages
Lab & Equipment
Technology
Solid Form Screening
Solid Form Developability Evaluation
Absolute Structure Determination
Crystallization Process Development
Conventional Oral Solid Dosage Forms
Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides
Mini-tablet
About Us
Our Company
Our History
Our People
Our Partner
Resources
News & Events
Knowledge Hub
Webinar Series
Careers
Talent Recruitment
Contact Us
Home
Customer Testimonials
Small Molecule
Mol2Med™ Integrated Services
Developability Assessment
Solid-State Characterization/FAST
pKa/LogP/LogD Measurements
Stability and Solubility Studies
In-Silico PBPK Modeling and Simulation
API Form and Solid-State Research
Solid Form Screening and Selection
Single Crystal Growth & Structure Determination
Solid-State NMR Analysis
Crystallization Development
Crystallization Development
Chiral Separation
Pre-formulation Studies
Comprehensive Physicochemical Property Evaluation
Excipient Selection and Compatibility Studies
Formulations for PK/Efficacy/Tox Studies
Animal Dosing Vehicle Selection
Amorphous Solid Dispersions
Formulation and Analytical Development
Formulation Development
Oral Solid Dosage Forms
Amorphous Solid Dispersion (Spray Drying & Hot-melt Extrusion)
Pediatric Formulation (Mini-tablet)
Analytical Chemistry
GMP Manufacturing
Clinical and Commercial Manufacturing
FIH-PMF-FMF Manufacturing
Clinical Supply
Crystal Bio
Competitive Advantages
Lab & Equipment
Technology
Solid Form Screening
Solid Form Developability Evaluation
Absolute Structure Determination
Crystallization Process Development
Conventional Oral Solid Dosage Forms
Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides
Mini-tablet
About Us
Our Company
Our History
Our People
Our Partner
Resources
News & Events
News
Events
Knowledge Hub
Technical Articles
Presentations
Case Studies
Whitepaper
ASD Series
Biologics
Webinar Series
Crystal Pharmatech Formulation Forum
2023-Mol2Med™ First-Time-Right Approach Webinar Series
Selecting the Right API Form and Formulation
Molecules-to-Medicine: Accelerating Drug Development through Collaboration
Advanced Characterization: Tools for Accelerating Molecules to Medicine
Crystal Bio Webinar
Careers
Talent Recruitment
Contact Us
E-mail us
+1-609-604-8303
bd_global@crystalpharmatech.com
cn
Small Molecule
Mol2Med™ Integrated Services
Developability Assessment
API Form and Solid-State Research
Crystallization Development
Pre-formulation Studies
Formulation and Analytical Development
GMP Manufacturing
Clinical Supply
Solid-State Characterization/FAST
pKa/LogP/LogD Measurements
Stability and Solubility Studies
In-Silico PBPK Modeling and Simulation
Solid Form Screening and Selection
Single Crystal Growth & Structure Determination
Solid-State NMR Analysis
Crystallization Development
Chiral Separation
Comprehensive Physicochemical Property Evaluation
Excipient Selection and Compatibility Studies
Formulations for PK/Efficacy/Tox Studies
Animal Dosing Vehicle Selection
Amorphous Solid Dispersions
Formulation Development
Oral Solid Dosage Forms
Amorphous Solid Dispersion (Spray Drying & Hot-melt Extrusion)
Pediatric Formulation (Mini-tablet)
Analytical Chemistry
Clinical and Commercial Manufacturing
FIH-PMF-FMF Manufacturing
Crystal Bio
Technology
Solid Form Screening
Solid Form Developability Evaluation
Absolute Structure Determination
Crystallization Process Development
Conventional Oral Solid Dosage Forms
Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides
Mini-tablet
About Us
Our Company
Our History
Our People
Our Partner
Resources
News & Events
Knowledge Hub
Webinar Series
News
Events
Technical Articles
Presentations
Case Studies
Whitepaper
ASD Series
Biologics
Crystal Pharmatech Formulation Forum
2023-Mol2Med™ First-Time-Right Approach Webinar Series
Selecting the Right API Form and Formulation
Molecules-to-Medicine: Accelerating Drug Development through Collaboration
Advanced Characterization: Tools for Accelerating Molecules to Medicine
Crystal Bio Webinar
Careers
Contact Us
Events
Home
Resources
News & Events
Events
Events
October 20-23, 2024
AAPS 2024 PHarmSCi 360
Events
October 16-17, 2024
Formulation & Delivery US 2024
Events
October 9-10, 2024
The 16th Drug Discovery Strategic Summit (DDSS) - San Francisco
Events
September 27-28, 2024
SAPA Annual Conference (Gold Corporate Sponsorship)
Events
September 16-17, 2024
14th American Drug Delivery and Formulation Summit (Exhibit)
Events
September 10-13, 2024
2024 CASSS - Mass Spec Symposium
Events
September 3-6, 2024
ChemOutsourcing 2024
Events
August 7-9, 2024
Immuno-Oncology Summit 2024 - Meet Crystal Bio at Booth 15
Events
August 19-22, 2024
The Bioprocessing Summit 2024 - Meet Crystal Bio at Booth T13
Events
June 25, 2024
Meet Crystal Pharmatech at 2024 Controlled & Modified Drug Release Summit
Events
June 8, 2024
Join Crystal Pharmatech for the Sino-American Pharmaceutical Professionals Association (SAPA) NE 26th Annual Conference
Events
June 3-6, 2024
Crystal Pharmatech will be in San Diego from June 3-6 at BIO International Convention
Events
May 13-16, 2024
Meet Crystal Pharmatech at AAPS National Biotechnology Conference
Events
May 11, 2024
Meet Crystal Pharmatech at Chinese Antibody Society 2024 Annual Conference
Events
May 8-9, 2024
Meet Crystal Pharmatech at 15th Drug Discovery Strategic Summit (DDSS)
Events
May 7, 2024
Meet Crystal Pharmatech at Sorption Symposium North America 2024
Events
May 7-9, 2024
CPHI North America - Meet Crystal Pharmatech at Booth 1441
Events
May 6-7, 2024
Meet Crystal Pharmatech at MIDD+ Boston 2024
Events
Apr 2, 2024
Formulation Development: Fastest-to-FIH Without Sacrificing Quality
Events
March 18-21, 2024
DCAT WEEK: CMC Discussions
Events
October 22-25, 2023
AAPS PharmSci360 - Meet Us at Booth # 2106
Events
April 25, 2023
Meet the Crystal Pharmatech formulation team next week at CPHI
Events
October 17-19, 2022
Crystal Pharmatech and the Future of Pharma at AAPS PharmSci 360
Events
September 7-9, 2022
Crystal Pharmatech Raring to Go to ChemOutsourcing 2022
Events
May 17-19. 2022
CPHI North america - Meet Us at Booth #530
Small Molecule
Mol2Med™ Integrated Services
Developability Assessment
API Form and Solid-State Research
Crystallization Development
Pre-formulation Studies
Formulation and Analytical Development
GMP Manufacturing
Clinical Supply
Technology
Quick Links
About Us
Events
Contact Us
bd_global@crystalpharmatech.com
+1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China, 215123
Sitemap
Privacy Policy
API Form and Solid-State Research
Solid Form Screening and Selection
Single Crystal Growth & Structure Determination
Solid-State NMR Analysis
Analytical Chemistry
Pre-formulation Studies
Formulation Development
Clinical and Commercial Manufacturing
Technology
Solid Form Screening
Solid Form Developability Evaluation
Absolute Structure Determination
Crystallization Process Development
Conventional Oral Solid Dosage Forms
Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides
Mini-tablet
Quick Links
About Us
Technical Articles
Events
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com
+1-609-604-8303
+1-609-604-8303
Your browser does not support VBScript!